|
Q4 FY2026
As of Jul 31, 2026
|
Q3 FY2026
As of Apr 30, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Oct 31, 2025
|
Q4 FY2025
As of Jul 31, 2025
|
Q3 FY2025
As of Apr 30, 2025
|
Q2 FY2025
As of Jan 31, 2025
|
Q1 FY2025
As of Oct 31, 2024
|
Q4 FY2024
As of Jul 31, 2024
|
Q3 FY2024
As of Apr 30, 2024
|
Q2 FY2024
As of Jan 31, 2024
|
Q1 FY2024
As of Oct 31, 2023
|
Q4 FY2023
As of Jul 31, 2023
|
Q3 FY2023
As of Apr 30, 2023
|
Q2 FY2023
As of Jan 31, 2023
|
Q1 FY2023
As of Oct 31, 2022
|
Q4 FY2022
As of Jul 31, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 31, 2022
|
Q1 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Security deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Current assets from discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Assets from Discontinued Operations | ||||||||||||||||||||
| Noncurrent assets from discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Convertible notes payable - related parties | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Unissued Stock | ||||||||||||||||||||
| Deferred Revenue | ||||||||||||||||||||
| Current liabilities from discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible notes payable, noncurrent - related parties | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Common stock, $0.001 par value; 250,000,000 shares authorized; 73,310,489 and 73,310,489 shares issued and 69,057,154 and 69,057,154 shares outstanding as of July 31, 2026 and July 31, 2025, respectively | ||||||||||||||||||||
| Treasury stock (4,253,335 and 4,253,335 shares held at July 31, 2026 and 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | ||||||||||||||||||||
Loading...
